Clinical Trials for CPX-351

1 Open Trial

Trial TypeProtocol No. &
Open Date
Summary
TreatmentVICCHEM1289
01/04/2013
Phase III, Multicenter, Randomized, Trial of CPX-351 (Cytarabine: Daunorubicin) Liposome Injection Versus Cytarabine and Daunorubicin in Patients 60-75 Years of Age with Untreated High Risk (Secondary) AML

Back to Find By Drug

You do not have JavaScript enabled. This site works better with JavaScript turned on.